Programmed Cell Death 1 抗体
(Programmed Cell Death 1 (PDCD1))
This gene encodes a cell surface membrane protein of the immunoglobulin superfamily. This protein is expressed in pro-B-cells and is thought to play a role in their differentiation. In mice, expression of this gene is induced in the thymus when anti-CD3 antibodies are injected and large numbers of thymocytes undergo apoptosis. Mice deficient for this gene bred on a BALB/c background developed dilated cardiomyopathy and died from congestive heart failure. These studies suggest that this gene product may also be important in T cell function and contribute to the prevention of autoimmune diseases. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| Recombinant PD-1 抗体 | 小鼠 | 兔 Chimeric |
|
|
|
| Recombinant PD-1 抗体 (Extracellular Domain) | 小鼠 | 兔 Chimeric |
|
|
|
| PD-1 抗体 (PE) | 人, Non-Human Primate | 小鼠 Monoclonal |
|
|
|
| PD-1 抗体 | 小鼠 | 大鼠 Monoclonal |
|
|
|
| PD-1 抗体 | 人 | 兔 Polyclonal |
|
|
|
| PD-1 抗体 (APC-iFluor™700) | 人 | 小鼠 Monoclonal |
|
|
|
| PD-1 抗体 (mFluor™450) | 人 | 小鼠 Monoclonal |
|
|
|
| PD-1 抗体 (Biotin) | 人 | 小鼠 Monoclonal |
|
|
|
| PD-1 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PD-1 抗体 (PE) | 人 | 小鼠 Monoclonal |
|
|
|
| PD-1 抗体 (iFluor™647) | 人 | 小鼠 Monoclonal |
|
|
|
| PD-1 抗体 (violetFluor™ 450) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| PD-1 抗体 (PE-Cy7) | 小鼠 | 大鼠 Monoclonal |
|
|
|
| PD-1 抗体 (PE) | 小鼠 | Armenian Hamster Monoclonal |
|
|
|
| PD-1 抗体 (AA 21-167) | 人 | 小鼠 Monoclonal |
|
|
|
| PD-1 抗体 (AA 22-170) | 人 | 小鼠 Monoclonal |
|
|
|
| PD-1 抗体 (AA 39-266) | 大鼠 | 兔 Polyclonal |
|
|
|
| PD-1 抗体 (AA 33-145) | 人 | 小鼠 Monoclonal |
|
|
|
| PD-1 抗体 (AA 1-288) | 人 | 兔 Polyclonal |
|
|
|
| PD-1 抗体 (AA 24-170) | 人 | 兔 Monoclonal |
|
|
Primary Antibody
- IF (Immunofluorescence: 有验证图片)
- FACS (Flow Cytometry: 所列应用)
- BR (Blocking Reagent: 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Chimeric
- 克隆
- RMP1-14
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
Primary Antibody
- ELISA (ELISA: 有验证图片)
- FACS (Flow Cytometry: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- Neut (Neutralization: 所列应用)
- Dep (Depletion: 所列应用)
- 适用
- 小鼠
- 宿主
- 兔
- 克隆形成能力
- Chimeric
- 克隆
- J43
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, lambda
- 抗原表位
- Extracellular Domain
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 人, Non-Human Primate
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- EH12-2H7
- 标记
- PE
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 质量等级
- GMP Grade (Analyte)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8G10
- 标记
- APC-iFluor™700
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 质量等级
- GMP Grade
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 6D5
- 标记
- mFluor™450
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 质量等级
- GMP Grade
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 6D5
- 标记
- Biotin
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 质量等级
- GMP Grade (Analyte)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8G10
- 标记
- PE
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 质量等级
- GMP Grade
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 8G10
- 标记
- iFluor™647
- 抗体亚型
- IgG1, kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- RMP1-30
- 标记
- violetFluor™ 450
- 抗体亚型
- IgG2b kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 小鼠
- 宿主
- 大鼠
- 克隆形成能力
- Monoclonal
- 克隆
- RMP1-30
- 标记
- PE-Cy7
- 抗体亚型
- IgG2b kappa
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- 适用
- 小鼠
- 宿主
- Armenian Hamster
- 克隆形成能力
- Monoclonal
- 克隆
- J43-1
- 标记
- PE
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 4F12
- 标记
- unconjugated
- 抗体亚型
- IgG2b kappa
- 抗原表位
- AA 21-167
Primary Antibody
- WB (Western Blotting: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 6B10
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 22-170
Primary Antibody
- IHC (Immunohistochemistry: 有验证图片)
- WB (Western Blotting: 所列应用)
- 适用
- 大鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 39-266
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 3B2
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 33-145
Primary Antibody
- WB (Western Blotting: 有验证图片)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-288
Primary Antibody
- FACS (Flow Cytometry: 有验证图片)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- DM177
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 24-170
Latest Publications for our Programmed Cell Death 1 抗体
: "Evaluation of costimulatory molecules in dogs with B cell high grade lymphoma." in: PLoS ONE, Vol. 13, Issue 7, pp. e0201222, (2019) (PubMed).
: "Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer." in: Journal of the National Cancer Institute, Vol. 110, Issue 3, pp. 316-320, (2019) (PubMed).
: "Low levels of SIV-specific CD8+ T cells in germinal centers characterizes acute SIV infection." in: PLoS pathogens, Vol. 15, Issue 3, pp. e1007311, (2019) (PubMed).
: "Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion." in: Oncogenesis, Vol. 8, Issue 3, pp. 17, (2019) (PubMed).
: "IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer." in: Scientific reports, Vol. 9, Issue 1, pp. 10353, (2019) (PubMed).
: "Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response." in: Clinical and experimental hepatology, Vol. 5, Issue 3, pp. 256-264, (2019) (PubMed).
: "Non-conventional Inhibitory CD4+Foxp3-PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity." in: Cancer cell, Vol. 33, Issue 6, pp. 1017-1032.e7, (2019) (PubMed).
: "Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability." in: Nature communications, Vol. 8, Issue 1, pp. 1323, (2018) (PubMed).
: "89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer." in: European journal of nuclear medicine and molecular imaging, Vol. 45, Issue 1, pp. 110-120, (2018) (PubMed).
: "Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza ..." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 200, Issue 2, pp. 538-550, (2018) (PubMed).
: "Immune Activation and Benefit From Avelumab in EBV-Positive Gastric Cancer." in: Journal of the National Cancer Institute, Vol. 110, Issue 3, pp. 316-320, (2019) (PubMed).
: "Low levels of SIV-specific CD8+ T cells in germinal centers characterizes acute SIV infection." in: PLoS pathogens, Vol. 15, Issue 3, pp. e1007311, (2019) (PubMed).
: "Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion." in: Oncogenesis, Vol. 8, Issue 3, pp. 17, (2019) (PubMed).
: "IL-17C-mediated innate inflammation decreases the response to PD-1 blockade in a model of Kras-driven lung cancer." in: Scientific reports, Vol. 9, Issue 1, pp. 10353, (2019) (PubMed).
: "Hepatic expression of programmed death-1 (PD-1) and its ligand, PD-L1, in children with autoimmune hepatitis: relation to treatment response." in: Clinical and experimental hepatology, Vol. 5, Issue 3, pp. 256-264, (2019) (PubMed).
: "Non-conventional Inhibitory CD4+Foxp3-PD-1hi T Cells as a Biomarker of Immune Checkpoint Blockade Activity." in: Cancer cell, Vol. 33, Issue 6, pp. 1017-1032.e7, (2019) (PubMed).
: "Genome-wide genetic and epigenetic analyses of pancreatic acinar cell carcinomas reveal aberrations in genome stability." in: Nature communications, Vol. 8, Issue 1, pp. 1323, (2018) (PubMed).
: "89Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer." in: European journal of nuclear medicine and molecular imaging, Vol. 45, Issue 1, pp. 110-120, (2018) (PubMed).
: "Quantitative Multiplexed Imaging Analysis Reveals a Strong Association between Immunogen-Specific B Cell Responses and Tonsillar Germinal Center Immune Dynamics in Children after Influenza ..." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 200, Issue 2, pp. 538-550, (2018) (PubMed).
Aliases for Programmed Cell Death 1 抗体
programmed cell death 1 (PDCD1) 抗体programmed cell death 1 (Pdcd1) 抗体
CD279 抗体
hPD-1 抗体
hPD-l 抗体
Ly101 抗体
PD-1 抗体
PD1 抗体
Pdc1 抗体
SLEB2 抗体
您还需要查找其他产品吗？
- Progesterone Receptor 抗体
- Progesterone 抗体
- Profilin 4 抗体
- Profilin 3 抗体
- Profilin 抗体
- PRODH2 抗体
- PRODH 抗体
- PROCR 抗体
- Procollagen, Type III 抗体
- Procollagen Type I Propeptide 抗体
- Procathepsin K 抗体
- Procalcitonin 抗体
- PROCA1 抗体
- PROC 抗体
- proBNP 抗体
- Pro-Platelet Basic Protein (Chemokine (C-X-C Motif) Ligand 7) 抗体
- PRO-ANP 抗体
- PRNP 抗体
- PRND 抗体
- PRMT8 抗体
- Programmed Cell Death 1 Ligand 2 抗体
- Programmed Cell Death 10 抗体
- Programmed Cell Death 4 抗体
- ProGRP 抗体
- Prohibitin 抗体
- Prohibitin 2 抗体
- PROK2 抗体
- Prokineticin 1 抗体
- Prokineticin Receptor 1 抗体
- Prokineticin Receptor 2 抗体
- PROL1 抗体
- Prolactin 抗体
- Prolactin Receptor 抗体
- Proliferating Cell Nuclear Antigen 抗体
- Proline Rich 13 抗体
- Proline Rich 15 抗体
- Proline Rich 15-Like 抗体
- Prominin 2 抗体
- PROP1 抗体
- Propionyl CoA Carboxylase, alpha Polypeptide 抗体
You are here:
